Literature DB >> 26696033

Race not rural residency is predictive of surgical treatment for hepatocellular carcinoma: Analysis of the Texas Cancer Registry.

Zeinab M Alawadi1,2, Uma R Phatak1,2, Lillian S Kao1,2, Tien C Ko2, Curtis J Wray1,2.   

Abstract

BACKGROUND AND OBJECTIVES: Rural patients have poor access to specialists and are less likely to receive evidence-based cancer care. We hypothesized that hepatocellular carcinoma (HCC) patients from rural counties in Texas would be less likely to receive surgical therapy than those from urban areas.
METHODS: The Texas Cancer Registry was queried (2000-2008). County-level data included "rural or urban" designation and income variables derived by zip code. Surgical intervention included: (i) ablation, (ii) resection-partial or total lobectomy, or (iii) transplantation. A multinomial logistic regression was created to determine predictors of intervention.
RESULTS: Five thousand thirty seven HCC patients were identified (86% urban) for study. A multinomial regression demonstrated, older age, African-American race, and lower income reduced the likelihood of ablation. Younger age, female gender, Caucasian, and Asian/other race predicted surgical resection, or transplantation. Hispanic race was associated with lower likelihood of resection (RRR 0.75) and transplantation (RRR 0.74), whereas African-American race was associated with pronounced decrease for transplantation (RRR 0.48). Area of residency was not predictive of intervention.
CONCLUSIONS: Rural residency did not decrease the likelihood of surgical intervention for hepatocellular carcinoma. Race and income continue to be associated with significant treatment disparity. Additional investigation should focus on factors that govern the selection of resection or transplantation for potentially eligible patients.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ablation; disparity; hepatocellular carcinoma; surgical resection; transplantation

Mesh:

Year:  2015        PMID: 26696033     DOI: 10.1002/jso.24101

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.

Authors:  Patricia D Jones; Carlos Diaz; Danlu Wang; Joselin Gonzalez-Diaz; Paul Martin; Erin Kobetz
Journal:  Dig Dis Sci       Date:  2017-12-23       Impact factor: 3.199

2.  Racial and Sex Disparities in Hepatocellular Carcinoma in the USA.

Authors:  Faith Ajayi; Jenny Jan; Amit G Singal; Nicole E Rich
Journal:  Curr Hepatol Rep       Date:  2020-11-12

3.  Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma.

Authors:  Juan Li; Bettina E Hansen; Maikel P Peppelenbosch; Robert A De Man; Qiuwei Pan; Dave Sprengers
Journal:  Oncotarget       Date:  2017-02-28

4.  Racial disparities in the survival time of patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma between Chinese patients and patients of other racial groups: A population-based study from 2004 to 2013.

Authors:  Fenggang Ren; Jing Zhang; Zhongyang Gao; Haoyang Zhu; Xue Chen; Wenyan Liu; Zhao Xue; Weiman Gao; Rongqian Wu; Yi Lv; Liangshuo Hu
Journal:  Oncol Lett       Date:  2018-10-05       Impact factor: 2.967

5.  Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular Carcinoma.

Authors:  Kali Zhou; Trevor A Pickering; Christina S Gainey; Myles Cockburn; Mariana C Stern; Lihua Liu; Jennifer B Unger; Anthony B El-Khoueiry; Norah A Terrault
Journal:  JNCI Cancer Spectr       Date:  2020-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.